Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05808712

Quality of Care in Relationship to Aborted Cancer Surgery

Surgery is often a central curative treatment for gastrointestinal tumors. Surgical treatment of diagnosed cancer tumors is decided after a comprehensive assessment of the patient's physical status, radiological assessments and after careful evaluation at the multidisciplinary conference. Despite the careful preoperative assessment of patients for curative surgery, the planned operation may unexpectedly need to be canceled. Of the patients who were planned for curative resection for pancreatic cancer in 2021 in Sweden, 90% received the intended surgery, and 10% of planned surgery was canceled. The reason for this was disseminated cancer or locally advanced disease in which radical resection is considered impossible to carry out. A systematic review of knowledge reveals a significant lack of evidence regarding patient-centered research and aborted cancer surgery.

The studies in the project have different study designs and methods, and include focus group interviews with staff, translation and validation of a questionnaire to measure care needs, estimation of supportive care needs and patient experiences.

An improved understanding and knowledge of patients' preferences and needs is needed to design interventions that can improve health-related quality of life. This project is dedicated to studying patients undergoing aborted cancer surgery, with the aim of improving the quality of care and meeting patients' care needs.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Surgery, Linköping, Sweden

Loading trial locations.

About this study

The overall objective of this research project is to:

  • describe the patients experiences and assess supportive care needs following aborted cancer gastrointestinal surgery
  • increase knowledge of the healthcare professionals' experiences of aborted cancer surgery from a multi-professional and continuum of cancer care perspective
  • increase our clinical knowledge of patient preferences and healthcare professionals' perspective to develop tailored patient-centered interventions with the goal to improve quality of cancer care

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • >18 years
  • cancer patients with different gastrointestinal cancer diagnosis

Exclusion criteria

  • not able to answer the questionnarie SCNS-SF34 in Swedish.

Treatment and study plan

Validation

Other

Translation and validation design

Primary outcomes

  1. supportive care needs, questonnarie

    Time frame: March 2023 - March 2024

    psychometric properties in the swedish version of the questionnarie SCNS-SF34

  2. Rate of supportive care needs in cancer

    Time frame: March 2023 - March 2024

    assessment of supportive care needs via the questionnarie SCNS-SF34 (in Swedish)

Study contacts

Contact information is provided by the study sponsor or research team.

Jenny Drott, PhD

CONTACT

[email protected]

+46 732701839

Per Sandström, Prof

CONTACT

[email protected]

+46 7034058581

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Registry information

Official study title

Developing Patient-centered Interventions to Improve the Quality of Care in Relationship to Aborted Cancer Surgery

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Apr 11, 2023
Registry last updated
Jun 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.